Search
Search Results
##search.searchResults.foundPlural##
-
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2781PDF: 980HTML: 4709 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2586PDF: 1223HTML: 11809 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3653PDF: 1123HTML: 23354 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6147PDF: 3333HTML: 9030Figure Malaria Ricci: 235 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4155PDF: 1977HTML: 1775 -
ADVANCES IN THE TREATMENT OF MALARIA
2876PDF: 1310HTML: 6002 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2065PDF: 847HTML: 261 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
2066PDF: 1644HTML: 14651Untitled: 216Untitled: 182 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2437PDF: 1601HTML: 651 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1052PDF: 945Suppl. Files: 596HTML: 89 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2223PDF: 1431HTML: 724 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1299PDF: 893HTML: 322 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
741PDF: 472HTML: 6273 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1759PDF: 858HTML: 152 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4840PDF: 1797HTML: 2723Untitled: 227 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3317PDF: 1257HTML: 8125 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2351PDF: 1863HTML: 151 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3364PDF: 1334HTML: 6203 -
-
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
101PDF: 79HTML: 14 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1293PDF: 1500Suppl. Files: 150HTML: 81 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
746PDF: 517HTML: 53 -
-
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3717PDF: 1309HTML: 745Figure 2: 459Figure 1: 3127 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2196PDF: 1324Html: 302 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2319PDF: 1340HTML: 17096Bassan Fig.1: 147Bassan Fig.2: 160Bassan Fig.4: 142Fig.3: 196







